Protection of CD3 δ knockout mice from lymphocytic choriomeningitis virus-induced immunopathology: Implications for viral neuroinvasion

Virology

Volumn 269, Issue 2, 2000, Pages 248-256

  Kappes, Dietmar J ^a   Lawrence, Diane M P ^a   Vaughn, Melinda M ^a   Davé, Vibhuti P ^a   Belman, Alec R ^a   Rall, Glenn F ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; DISEASE COURSE; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ANIMALIA; CHORIOMENINGITIS VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MURINAE; RNA VIRUSES;

EID: 0034630177     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0224     Document Type: Article

References (29)

1. Anlar B. SSPE: Diagnosis and drug treatment options. CNS Drugs. 7:1997;111-120.
2. + T cells contribute to tissue destruction during Borna disease. J. Immunol. 153:1994;818-823.
3. Borrow P., Oldstone M. B. A. Lymphocytic choriomeningitis virus. Nathanson N. Viral Pathogenesis. 1997;593-627 Lippincott-Raven, Philadelphia.
4. Buchmeier M., Welsh R., Dutko F., Oldstone M. The virology and immunobiology of LCMV infection. Adv. Immunol. 30:1980;275-331.
5. Buchmeier M. J., Zajac A. J. Lymphocytic choriomeningitis virus. Ahmed R. Persistent Viral Infections. 1999;575-605.
6. Byrne J. A., Oldstone M. B. A. Biology of cloned CTLs specific for LCMV: Clearance of virus in vivo. J. Virol. 51:1984;682-686.
7. Cole G. A., Gilden D., Monjan A., Nathanson N. LCMV: Pathogenesis of acute CNS disease. Fed. Proc. 30:1971;1831-1841.
8. Davé V. P., Cao Z., Browne C., Alarcon B., Fernandez-Miguel G., Lafille J., Hera A. D. I., Tonegawa S., Kappes D. J. CD3 delta deficiency arrests development of the alpha-beta but not the gamma-delta cell lineage. EMBO J. 16:1997;1360-1370.
9. Duguid J., Trzepacz C. Major histocompatibility complex genes have an increased brain expression after scrapie infection. Proc. Natl. Acad. Sci. USA. 90:1993;114-117.
10. Dutko F. J., Oldstone M. B. A. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64:1983;1689-1698.
11. Fazakerley J. K., Southern P., Bloom F., Buchmeier M. J. High resolution in situ hybridization to determine the cellular distribution of LCMV RNA in the tissues of persistently infected mice: Relevance to arenavirus disease and mechanisms of viral persistence. J. Gen. Virol. 72:1991;1611-1625.
12. Gogate N., Swoveland P., Yamabe T., Verma L., Woyciechowska J., Tarnowska-Dziduszko E., Dymecki J., Dhib-Jalbut S. MHC class I expression on neurons in SSPE and experimental subacute measles encephalitis. J. Neuropathol. Exp. Neurol. 55:1996;435-443.
13. Gooding L. R. Virus proteins that counteract host immune defenses. Cell. 71:1992;5-7.
14. Hotchin J. The biology of LCMV infection: Virus-induced immune disease. Cold Spring Harbor Symp. Quant. Biol. 27:1962;479-499.
15. Joly E., Mucke L., Oldstone M. B. A. Viral persistence in neurons explained by a lack of MHC class I expression. Science. 253:1991;1283-1285.
16. Kappes D. J., Alarcon B., Reguiero J. T lymphocyte receptor deficiencies. Curr. Opin. Immunol. 7:1995;441-447.
17. Lillie R. D., Armstrong C. Pathology of LCMV in mice. Arch. Pathol. 40:1945;141-152.
18. Mucke L., Oldstone M. B. A. The expression of MHC class I antigens in the brain differs markedly in acute and persistent infections with LCMV. J. Neuroimmunol. 36:1992;193-198.
19. Neumann H., Cavalie A., Jenne D. E., Wekerle H. Induction of MHC class I genes in neurons. Science. 269:1995;549-552.
20. Neumann H., Schmidt H., Cavalie A., Jenne D., Wekerle H. MHC class I gene expression in single neurons of the central nervous system: Differential regulation by interferon gamma and tumor necrosis factor alpha. J. Exp. Med. 185:1997;305-316.
21. Oldstone M. B. A. How viruses escape from cytotoxic T lymphocytes: Molecular parameters and players. Virology. 234:1997;179-185.
22. Oldstone M. B. A., Ahmed R., Buchmeier M. J., Blount P., Tishon A. Perturbation of differentiation functions during viral infections in vivo. I. Relationship of lymphocytic choriomeningitis virus and host strains to growth hormone deficiency. Virology. 142:1985;158-174.
23. Oldstone M. B. A., Blount P., Southern P. J., Lampert P. W. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature. 321:1986;239-243.
24. Pearce B. D., Hobbs M. V., McGraw T. S., Buchmeier M. J. Cytokine induction during T cell mediated clearance of mouse hepatitis virus from neurons in vivo. J. Virol. 68:1994;5483-5495.
25. Ploegh H. L. Viral strategies of immune evasion. Science. 280:1998;248-253.
26. Rall G. F. CNS neurons: The basis and benefits of low MHC expression. Curr. Top. Microbiol. Immunol. 232:1998;115-134.
27. Rall G. F., Mucke L., Oldstone M. B. A. Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex-expressing neurons in vivo. J. Exp. Med. 182:1995;1201-1212.
28. Rall G. F., Oldstone M. B. A. Viral persistence in the CNS. Peterson P. K., Remington J. S. In Defense of the Brain. 1997;273-289 Blackwell Press, Cambridge.
29. Sedgwick J. D., Dörries R. The immune system response to viral infection of the CNS. Semin. Neurosci. 3:1991;93-100.